[ @entity957 of the male XXXX . Our experience in 5 cases].

@entity1 @entity295 @entity548 @entity5 @entity957 @entity18485 @entity189 @entity292 @entity733 @entity3832 @entity3
OBJECTIVES: @entity957 of the male @entity18485 is a rare @entity5 that accounts for 70% of primary @entity5 of the @entity18485 . The present study reviews our experience of 5 years in the diagnosis and treatment of this @entity5 type. METHODS: From 1991 to 1994, we diagnosed and treated 5 male @entity1 with @entity957 of the @entity18485 ; mean age 58 years (range 43 to 76 years). The @entity5 was localized in the bulbomembranous @entity18485 in 3 cases (60%) and in the penile @entity18485 in the remaining 2 cases (40%). All @entity1 presented with @entity3832 following treatment (internal urethrotomy and dilatation). The @entity5 of the posterior @entity18485 were Levine stage C and D at the time of diagnosis, while those of the anterior @entity18485 were Levine stage B and C. RESULTS: Two @entity1 with @entity5 in the posterior @entity18485 underwent radical cystoprostatourethrectomy and bilateral inguinal lymphadenectomy, whereas the remaining @entity1 underwent emasculation or urethrectomy. @entity1 survival has ranged from 1 to 2.5 years at the present time. One @entity1 with @entity5 in the bulbous @entity18485 has died despite postoperative radio and chemotherapy, the outcome has been poor in another @entity1 with @entity5 in the posterior @entity18485 and no progression has been observed in the remaining @entity1 at present. CONCLUSIONS: a) @entity3832 with a torpid course and localized complications ( @entity292 , @entity733 , etc.) following standard therapy have been the only widely accepted etiologic factors that we have observed in our @entity1 ; b) This @entity5 type must be suspected since treatment by radical surgery will have some likelihood of success if the @entity189 is diagnosed early, while it is still localized; c) To date, radio and chemotherapy have achieved poor results, the former being effective in @entity5 of the penile @entity18485 only when given at a high dose; d) @entity1 generally die from localized complications, @entity5 recurrence, or lymph node @entity3 ( @entity295 , @entity548 , etc.).
